Welcome to our dedicated page for GFUZ news (Ticker: GFUZ), a resource for investors and traders seeking the latest updates and insights on GFUZ stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GFUZ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GFUZ's position in the market.
General Fusion (Nasdaq: GFUZ) began trading on Nasdaq on July 13, 2026, following its business combination with Spring Valley Acquisition Corp. III. The company enters public markets with approximately US$150 million in cash to fund its Lawson program through key Magnetized Target Fusion (MTF) milestones targeted for 2028.
General Fusion highlights progress on its LM26 demonstration machine in Vancouver, reporting plasma electron temperatures of about 0.72 keV (8.4 million °C) toward a 1 keV goal. The company cites global recognition via TIME’s 2026 Top GreenTech ranking, board reinforcements, and a framework agreement with Renexia for potential commercial deployment in Italy.
General Fusion Group (Nasdaq: GFUZ) has completed its previously announced business combination with Spring Valley Acquisition Corp. III, a Nasdaq-listed SPAC, and will begin trading on Nasdaq under the ticker symbols “GFUZ” (shares) and “GFUZW” (warrants) on July 13, 2026.
According to General Fusion, the company is entering public markets with approximately US$150 million in cash, including net proceeds from a private placement and SPAC trust capital. The funds are expected to support its Lawson program through several key technical milestones targeted for completion in 2028, with the goal of demonstrating and de-risking its Magnetized Target Fusion (MTF) technology at commercially relevant scale.
The company operates Lawson Machine 26 (LM26), described as the first MTF demonstration machine at a commercially relevant scale. LM26 compresses plasma with a lithium liner at roughly 50% commercial-scale diameter and is intended to reach plasma temperatures of 1 keV and 10 keV on the path toward meeting the Lawson criterion for net fusion energy.